TrialSignal
Clinical trial intelligence report
Effects of Telomerase Reactivation With Danazol in Ovarian Function.
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT04058678-Jul 28, 2026
NCT ID
NCT04058678
Status
COMPLETED
Phase
NA
Sponsor
IVI Madrid
Executive brief
Investment-Ready Snapshot
Effects of Telomerase Reactivation With Danazol in Ovarian Function. is a NA clinical asset sponsored by IVI Madrid in Ovarian Reserve. SEO and diligence focus: Danazol/Placebo, Without intervention, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT04058678
Indication
Ovarian Reserve
Modality
small molecule
Target
Danazol/Placebo, Without intervention
Intervention
Danazol/Placebo, Without intervention
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.